|
Noted
physician Dr. S N Arya said on Saturday that Kojak Selinge could prevent
diseases caused by the use of recycled syringes across te world. The Hindustan
Syringes and Medical Devices (HMD) on Saturday launched India’s first
auto-disable (non-reusable) syringe, Kojak Selinge, in Patna. Any attempt to
recycle the syringe leads to the breaking of the plunger. The plunger get locks
after administration of a dose to patient making it impossible to reuse the
syringe. Earlier, the use of auto-disable (AD) syringes was restricted to
immunization only but now many countries are planning to replace the standard
disposable syringes with AD syringes.
Arya
said the according to an estimate, over Rs 2,675 crore was spent every year
world over on the treatment of diseases caused by the use of recycled syringes.
They include HIV, Hepatitis B and C and Malaria. Narrating his personal
experience, Arya said that his wife, an arthritis patient, fell victim to
Hepatitis B caused due to the use of recycled syringe to administer pain killing
injections to her. He, however, advised the HMD authorities to take care of the
quality of their product. The vice-chairman of national board of examination (NBE)
Dr. D K Chaudhary and top gynecologist Dr Manju Gita Mishra said that the use of
recycled syringes was causing havoc in the entire country. He said that recycled
syringes accounted for 8-10 percent of the total cases of Aids in the world.
Chaudhary, a noted surgeon, said that the presence of even 0.1 per cent of blood
of an HIV carrier on the HIV to normal persons if he/she happened to receive an
injection from a recycled syringe.
Similarly, he said that the presence of 0.06 per cent of blood of a Hepatitis B
infected person on the needles of a syringe could cause Hepatitis B another
person. Both Chaudhary and Mishra requested the manufacturer of Kojak Selinge
not to compromise on the quality, HMD is the first company in the world to have
introduced low cost AD syringes. The general manager (marketing) of the company
Pradeep Sareen said that the problem of injection was so alarming that recently
WHO, UNESCO and UNFPA had to issue a joint policy statement on the urgent need
to implement a safe injection policy.
In the
joint statement, Sareen added, It was also said that henceforth UNICEF will
stick to the policy of not even entering into any agreement with any company to
procure standard disposable syringes for its immunization programme. Quoting a
WHO study, Sareen said that the cost of injection from non reusable syringes was
eight time cheaper that sterlisable glass syringes and six time cheaper than the
ordinary disposable syringes.
Price
at Rs. 5.25 per piece for 2ml, Kojak Selinge is available in sizes of 0.5 ml,
2ml and 5ml and 10ml. HMD is also producing Dispovan and Glassvan syringes. He
said that the cost of treatment of Hepatitis B and C was Rs. 2.5 lakh to Rs 10
lakh and that of Aids Rs 5 lakh to Rs 50 lakh. |
